US production of Pfizer's Paxlovid to expand

Vaccine-maker Pfizer said Monday that it would invest $120 million at its facility in Michigan, boosting U.S.-based production of the PAXLOVID coronavirus pill.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.